WallStreetZenWallStreetZen

NASDAQ: CYCN
Cyclerion Therapeutics Inc Stock Ownership - Who owns Cyclerion Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cyclerion Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter M. HechtDirector2025-03-25181,818$2.75
$500.00kBuy
Michael J. 1. HigginsDirector2025-03-259,090$2.75
$25.00kBuy

1 of 1

CYCN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCN insiders and whales buy or sell their stock.

CYCN Shareholders

What type of owners hold Cyclerion Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Terrance McGuire19.65%771,191$1.50MInsider
Amy W. Schulman16.14%633,625$1.24MInsider
Peter M. Hecht14.26%559,760$1.09MInsider
Andreas Busch6.49%254,704$496.67kInsider
Mark G. Currie6.41%251,648$490.71kInsider
Siren LLC2.96%116,155$226.50kInstitution
Regina Margaret Graul2.56%100,303$195.59kInsider
William Huyett1.72%67,590$131.80kInsider
Drw Securities LLC1.11%43,617$85.05kInstitution
Christopher I. Wright1.09%42,728$83.32kInsider

1 of 3

CYCN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCN6.59%72.50%Net Buying
KTTA6.25%93.75%Net BuyingNet Buying
TCRT0.23%99.77%Net BuyingNet Buying
RNAZ0.41%99.59%
PPCB0.84%0.00%
View Top Biotech Stocks

Cyclerion Therapeutics Stock Ownership FAQ

Who owns Cyclerion Therapeutics?

Cyclerion Therapeutics (NASDAQ: CYCN) is owned by 6.59% institutional shareholders, 72.50% Cyclerion Therapeutics insiders, and 20.91% retail investors. Terrance McGuire is the largest individual Cyclerion Therapeutics shareholder, owning 771,191.00 shares representing 19.65% of the company. Terrance McGuire's Cyclerion Therapeutics shares are currently valued at $1.39M.

If you're new to stock investing, here's how to buy Cyclerion Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.